Federal Trade Commission
| Title | Link |
|---|---|
| FTC - In the Matter of 180-Day Generic Drug Exclusivity for Abbreviated New Drug Applications - Comment of the Staff of the Bureau of Competition and of Policy Planning of the FTC - November 4, 1999 | http://www.ftc.gov/be/v990016.htm |
| FTC - Miracle health Claims, Add a Dose of Skeptici | http://www.ftc.gov/bcp/conline/pubs/health/frdhea |
| U.S. Federal Trade Commission - home page | http://www.ftc.gov/ |
| U.S. Department of Justice and the Federal Trade Commission - Antitrust Guidelines for the Licensing of Intellectual Property - April 1996 | http://www.usdoj.gov/atr/public/guidelines/ipguide.htm |
| Department of Justice and Federal Trade Commission - Statements of antitrust enforcement policy in health care | http://www.ftc.gov/reports/hlth3s.htm |
| FTC Antitrust Actions in health care services and products - June 2001 | http://www.ftc.gov/bc/hcindex/hcupdate.pdf |
| FTC
- Analysis to Aid Public Comment - proposed consent order with Hoechst
Marion Roussel, Inc. (“HMR”), Carderm Capital, L.P. (“Carderm”), and Andrx Corporation (“Andrx”) - (7 pages9 |
http://www.ftc.gov/os/2001/04/hoechstanalysis.pdf |
| FTC - Complaint - against Schering-Plough Corporation, Upsher-Smith Laboratories, American Home Products Corporation, | http://www.ftc.gov/os/2001/04/scheringpart3cmp.pdf |
| FTC - Antitrust Guidelines for Collaborations Among Competitors - April 2000 - (39 pages) | http://www.ftc.gov/os/2000/04/ftcdojguidelines.pdf |
| FTC - Marketer of Herbal Supplement Products Agrees to Settle FTC Charges That Safety and Health Benefit Claims Were False | http://www.ftc.gov/opa/2001/12/chrisenterprises2.htm |
| FTC - Statement of the Federal Trade Commission's Bureau of Consumer Protection On the National Cancer Institute's Report on Cigarette Testing Method - November 27, 2001 | http://www.ftc.gov/opa/2001/11/ncistudy.htm |
| FTC - Statement of Susan A. Creighton, Deputy Director, Bureau of Competition Regarding FTC Settlement with Hearst Corporation - November 20, 2001 - news release | http://www.ftc.gov/opa/2001/11/hearst.htm |
| FTC - Five Manufacturers of Over-the-Counter Analgesic Products Agree to Settle Charges of Mislabeling Certain Products as "Made in USA" - November 6, 2001 - press release | http://www.ftc.gov/opa/2001/11/musa.htm |
| FTC -FTC Staff Comments on FDA’s Plans to Collect Information on Direct-To-Consumer Prescription Drug Advertising - September 24, 2001 - | http://www.ftc.gov/be/v010008.htm |
| Dennis Murphy, Theodore H. Hoppock and Michelle K. Rusk - A Generic Copy Test of Food Health Claims in Advertising - November 1998 | http://www.ftc.gov/os/1998/9811/netfood.pdf |
| Bureau of Economics with the Bureau of Competition and the Bureau of Consumer Protection - Competition and the Financial Impact of the Proposed Tobacco Industry Settlement - September 1997 | http://www.ftc.gov/reports/tobacco/ndoc95.pdf |
| FTC - Dietary Supplements: An Advertising Guide for Industry - (32 pages) | http://www.ftc.gov/bcp/conline/pubs/buspubs/dietsupp.pdf |
| FTC - Enforcement Policy Statement on Food Advertising - May 1994 | http://www.ftc.gov/bcp/policystmt/ad-food.htm |
| FTC - List of documents on tobacco | http://www.ftc.gov/bcp/menu-tobac.htm |
| Speech of Thomas B. Leary - FTC - Antitrust Issues in the Settlement of Pharmaceutical Patent Disputes, Part II | http://www.ftc.gov/speeches/leary/learypharmaceuticalsettlement.htm http://www.ftc.gov/speeches/leary/learypharma.htm |
| Complaint of the FTC Schering-Plough Corporation v. and American Home Products Corporation, | http://www.ftc.gov/os/2001/04/scheringpart3cmp.pdf |
| FTC -Generic Drug Competition: Request for Public Comment on Proposed Commission Information Request to Firms In the Pharmaceutical Industry. - Agency Information Collection Activities; Proposed Collection; Comment Request - Federal Register Notice | http://www.ftc.gov/os/2000/10/frngenericdrugstudy.htm |
| FTC - Memorandum of law - of Amicus Curiae - in opposition to defendant's motion to dismiss -In re: Buspirone Patent Litigation - In re: Buspirone Antitrust Litigation - (37 pages) | http://www.ftc.gov/os/2002/01/busparbrief.pdf |
Back to country: United States
Last updated: April 18, 2002